Laddar...
FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity
AIMS: The clinical use of doxorubicin for the treatment of cancer is limited by its cardiotoxicity. Flavaglines are natural products that have both potent anticancer and cardioprotective properties. A synthetic analog of flavaglines, FL3, efficiently protects mice from the cardiotoxicity of doxorubi...
Sparad:
| I publikationen: | PLoS One |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Public Library of Science
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4633129/ https://ncbi.nlm.nih.gov/pubmed/26536361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141826 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|